BACE1 is an aspartyl protease that contributes to the pathogenesis of Alzheimer’s disease, and targeting BACE1 has been a long-sought-after strategy for treating Alzheimer’s disease [74]. Here, BACE1 is linked to early-onset autosomal dominant Alzheimer disease.